Constitutive activity of Erk1/2 and NF-κB protects human endometrial stromal cells from death receptor-mediated apoptosis

Reproductive Biology

Volumn 13, Issue 2, 2013, Pages 113-121

  Fluhr, Herbert ^a   Spratte, Julia ^a   Bredow, Marike ^a   Heidrich, Stephanie ^a   Zygmunt, Marek ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Apoptosis; Death receptor; Endometrium; Erk1 2; NF B

Indexed keywords

EID: 84883814416     PISSN: 1642431X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repbio.2013.03.001     Document Type: Article

References (37)

1. Harada T., Kaponis A., Iwabe T., Taniguchi F., Makrydimas G., Sofikitis N., et al. Apoptosis in human endometrium and endometriosis. Human Reproduction Update 2004, 10:29-38.
2. Keogh R.J., Harris L.K., Freeman A., Baker P.N., Aplin J.D., Whitley G.S., et al. Fetal-derived trophoblast use the apoptotic cytokine tumor necrosis factor-alpha-related apoptosis-inducing ligand to induce smooth muscle cell death. Circulation Research 2007, 100:834-841.
3. Phillips T.A., Ni J., Hunt J.S. Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta 2001, 22:663-672.
4. Abrahams V.M., Straszewski-Chavez S.L., Guller S., Mor G. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Molecular Human Reproduction 2004, 10:55-63.
5. Uckan D., Steele A., Cherry, Wang B.Y., Chamizo W., Koutsonikolis A., et al. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Molecular Human Reproduction 1997, 3:655-662.
6. Haider S., Knofler M. Human tumour necrosis factor: physiological and pathological roles in placenta and endometrium. Placenta 2009, 30:111-123.
7. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling. Cell Death and Differentiation 2003, 10:45-65.
8. Nagata S. Apoptosis by death factor. Cell 1997, 88:355-365.
9. Wajant H., Pfizenmaier K., Scheurich P. Non-apoptotic Fas signaling. Cytokine and Growth Factor Reviews 2003, 14:53-66.
10. Falschlehner C., Emmerich C.H., Gerlach B., Walczak H. TRAIL signalling: decisions between life and death. International Journal of Biochemistry and Cellular Biology 2007, 39:1462-1475.
11. Igney F.H., Krammer P.H. Death and anti-death: tumour resistance to apoptosis. Nature Reviews Cancer 2002, 2:277-288.
12. Fulda S., Meyer E., Debatin K.M. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Research 2000, 60:3947-3956.
13. Curtin J.F., Cotter T.G. Live and let die: regulatory mechanisms in Fas-mediated apoptosis. Cellular Signalling 2003, 15:983-992.
14. Fluhr H., Krenzer S., Stein G.M., Stork B., Deperschmidt M., Wallwiener D., et al. Interferon-gamma and tumor necrosis factor-alpha sensitize primarily resistant human endometrial stromal cells to Fas-mediated apoptosis. Journal of Cell Science 2007, 120:4126-4133.
15. Fluhr H., Sauter G., Steinmuller F., Licht P., Zygmunt M. Nonapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on interleukin-6, leukemia inhibitory factor, interleukin-8, and monocyte chemoattractant protein 1 vary between undifferentiated and decidualized human endometrial stromal cells. Fertility and Sterility 2009, 92:1420-1423.
16. Fluhr H., Wenig H., Spratte J., Heidrich S., Ehrhardt J., Zygmunt M. Non-apoptotic Fas-induced regulation of cytokines in undifferentiated and decidualized human endometrial stromal cells depends on caspase-activity. Molecular Human Reproduction 2011, 17:127-134.
17. Fluhr H., Spratte J., Ehrhardt J., Steinmuller F., Licht P., Zygmunt M. Heparin and low-molecular-weight heparins modulate the decidualization of human endometrial stromal cells. Fertility and Sterility 2010, 93:2581-2587.
18. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. Journal of Immunological Methods 1991, 139:271-279.
19. Martin S.J., Lennon S.V., Bonham A.M., Cotter T.G. Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. Journal of Immunology 1990, 145:1859-1867.
20. Natoli G., Ianni A., Costanzo A., De Petrillo G., Ilari I., Chirillo P., et al. Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 1995, 11:1157-1164.
21. Higami Y., Tanaka K., Tsuchiya T., Shimokawa I. Intravenous injection of cycloheximide induces apoptosis and up-regulates p53 and Fas receptor expression in the rat liver in vivo. Mutation Research 2000, 457:105-111.
22. Brumatti G., Yon M., Castro F.A., Bueno-da-Silva A.E., Jacysyn J.F., Brunner T., et al. Conversion of CD95 (Fas) type II into type I signaling by sub-lethal doses of cycloheximide. Experimental Cell Research 2008, 314:554-563.
23. Abraham M.C., Shaham S. Death without caspases, caspases without death. Trends in Cellular Biology 2004, 14:184-193.
24. Kroemer G., Martin S.J. Caspase-independent cell death. Nature Medicine 2005, 11:725-730.
25. Kuranaga E., Miura M. Nonapoptotic functions of caspases: caspases as regulatory molecules for immunity and cell-fate determination. Trends in Cellular Biology 2007, 17:135-144.
26. Abe H., Shibata M.A., Otsuki Y. Caspase cascade of Fas-mediated apoptosis in human normal endometrium and endometrial carcinoma cells. Molecular Human Reproduction 2006, 12:535-541.
27. Li A., Felix J.C., Hao J., Minoo P., Jain J.K. Menstrual-like breakdown and apoptosis in human endometrial explants. Human Reproduction 2005, 20:1709-1719.
28. Maruo T., Laoag-Fernandez J.B., Pakarinen P., Murakoshi H., Spitz I.M., Johansson E. Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium. Human Reproduction 2001, 16:2103-2108.
29. Meresman G.F., Olivares C., Vighi S., Alfie M., Irigoyen M., Etchepareborda J.J. Apoptosis is increased and cell proliferation is decreased in out-of-phase endometria from infertile and recurrent abortion patients. Reproductive Biology and Endocrinology 2010, 8:126.
30. Jasinska A., Strakova Z., Szmidt M., Fazleabas A.T. Human chorionic gonadotropin and decidualization in vitro inhibits cytochalasin-D-induced apoptosis in cultured endometrial stromal fibroblasts. Endocrinology 2006, 147:4112-4121.
31. Lovely L.P., Fazleabas A.T., Fritz M.A., McAdams D.G., Lessey B.A. Prevention of endometrial apoptosis: randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase. Journal of Clinical Endocrinology and Metabolism 2005, 90:2351-2356.
32. Holmstrom T.H., Tran S.E., Johnson V.L., Ahn N.G., Chow S.C., Eriksson J.E. Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis. Molecular and Cellular Biology 1999, 19:5991-6002.
33. Sugiyama H., Savill J.S., Kitamura M., Zhao L., Stylianou E. Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells. Journal of Biological Chemistry 1999, 274:19532-19537.
34. Diessenbacher P., Hupe M., Sprick M.R., Kerstan A., Geserick P., Haas T.L., et al. NF-kappaB inhibition reveals differential mechanisms of TNF versus TRAIL-induced apoptosis upstream or at the level of caspase-8 activation independent of cIAP2. Journal of Investigative Dermatology 2008, 128:1134-1147.
35. Hatano E., Brenner D.A. Akt protects mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis through NK-kappa B activation. American Journal of Physiology and Gastrointestinal Liver Physiology 2001, 281:G1357-G1368.
36. Straszewski-Chavez S.L., Abrahams V.M., Aldo P.B., Romero R., Mor G. AKT controls human first trimester trophoblast cell sensitivity to FAS-mediated apoptosis by regulating XIAP expression. Biology of Reproduction 2010, 82:146-152.
37. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochemistry Journal 2000, 351:95-105.